Citigroup Inc Merrimack Pharmaceuticals Inc Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$13.06 - $15.0 $5,015 - $5,760
384 Added 24.43%
1,956 $28,000
Q4 2023

Feb 09, 2024
BUY
$12.02 - $13.41 $18,606 - $20,758
1,548 Added 6450.0%
1,572 $21,000
Q3 2023

Nov 09, 2023
SELL
$11.6 - $12.52 $35,878 - $38,724
-3,093 Reduced 99.23%
24 $0
Q2 2023

Aug 10, 2023
BUY
$12.02 - $13.07 $37,466 - $40,739
3,117 New
3,117 $38,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email